TY - JOUR
T1 - Securing the future of drug discovery for central nervous system disorders
AU - Andersen, Peter Høngaard
AU - Moscicki, Richard
AU - Sahakian, Barbara
AU - Quirion, Rémi
AU - Krishnan, Ranga
AU - Race, Tim
AU - Phillips, Anthony
AU - AUTHOR GROUP
AU - Abe, Michikazu
AU - Baker, Mary
AU - Chlebus, Magda
AU - Connolly, Enda
AU - Craven, Audrey
AU - de Visser, Marianne
AU - Dean, Brian
AU - Dolmetsch, Ricardo
AU - Duffy, Ciaran
AU - Falkai, Peter
AU - Fontoura, Paulo
AU - Hamburg, Karin
AU - Higuchi, Teruhiko
AU - Insel, Tom
AU - Jones, Declan
AU - Kapur, Shitij
AU - Kasper, Siegfried
AU - Kato, Tadafumi
AU - Kimura, Tatsuya
AU - Kirkpatrick, Peter
AU - Klingmann, Ingrid
AU - Marsling, Stine Hove
AU - Minchin, Michael
AU - Möller, Hans-Jürgen
AU - Mosciki, Richard
AU - Nakabayashi, Tetsuo
AU - Ni, Keni
AU - Owa, Takashi
AU - Ozaki, Norio
AU - Simic, Zoran
AU - Stolk, Pieter
AU - Suhara, Tetsuya
AU - Sulcova, Alexandra
AU - Wilkerson, Bill
AU - Yamada, Masaki
AU - Yamawaki, Shigeto
AU - Yamori, Takao
AU - Zohar, Joseph
AU - Zvartau-Hind, Marina
PY - 2014
Y1 - 2014
N2 - Innovative partnerships among researchers, patients, regulators, payors and industry are needed to reinvigorate drug discovery for central nervous system disorders. Here, we summarize plans of the Collegium Internationale Neuro-Psychopharmacologicum (CINP) to achieve this goal
AB - Innovative partnerships among researchers, patients, regulators, payors and industry are needed to reinvigorate drug discovery for central nervous system disorders. Here, we summarize plans of the Collegium Internationale Neuro-Psychopharmacologicum (CINP) to achieve this goal
U2 - https://doi.org/10.1038/nrd4489
DO - https://doi.org/10.1038/nrd4489
M3 - Editorial
C2 - 25435203
SN - 1474-1776
VL - 13
SP - 871
EP - 872
JO - Nature reviews. Drug discovery
JF - Nature reviews. Drug discovery
IS - 12
ER -